Buhisan, Maisalam Y.
HRN: 27-41-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/01/2025
07/08/2025
IV
4.5gms
Q6
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes